MoneyWorks4Me

Gufic Biosciences - Quaterly Results

11 Nov 2022 Evaluate
A decrease in the sales to Rs. 1748.35 millions was observed for the quarter ended September 2022. The sales stood at Rs. 1941.39 millions during the similar quarter previous year.The Net proft of the company remain more or less same to Rs. 202.12  millions from Rs. 233.35 millions ,decline by -13.38%.Operating Profit reported a sharp decline to 334.31 millions from 361.34 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 1748.35 1941.39 -9.94 3401.11 4448.97 -23.55 7791.56 4876.99 59.76
Other Income 8.18 3.05 168.20 11.93 15.33 -22.18 31.04 37.33 -16.85
PBIDT 334.31 361.34 -7.48 669.85 830.10 -19.30 1488.20 876.53 69.78
Interest 16.06 15.49 3.68 25.14 27.58 -8.85 48.47 136.33 -64.45
PBDT 318.25 345.85 -7.98 644.71 802.52 -19.66 1439.73 740.20 94.51
Depreciation 45.64 41.97 8.74 89.29 83.23 7.28 171.34 163.08 5.06
PBT 272.61 303.88 -10.29 555.42 719.29 -22.78 1268.39 577.12 119.78
TAX 70.49 70.53 -0.06 142.78 173.87 -17.88 309.98 134.80 129.96
Deferred Tax -6.51 -6.17 5.51 -7.82 -8.43 -7.24 -11.52 20.11 -157.28
PAT 202.12 233.35 -13.38 412.64 545.42 -24.34 958.41 442.32 116.68
Equity 96.94 96.94 0.00 96.94 96.95 -0.01 96.94 96.94 0.00
PBIDTM(%) 19.12 18.61 2.74 19.70 18.66 5.56 19.10 17.97 6.27
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..